Long Term Consequences of Acute Inflammation in Cancer Surgery

Patrice Forget, Marc De Kock

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Perioperative inflammation assessment can be used to screen and stratify the perioperative status of the cancer patient. Biomarkers such as the neutrophil-to-lymphocyte ratio help clinicians and researchers develop and apply new screening and monitoring strategies. To control the perioperative inflammatory reaction, and to promote early resolution, pharmacological interventions such as NSAIDs are proposed as promising. One of their applications is the prevention of the early peak of recurrence, seen in the first few years after surgery. Additionally, to progress toward the development of new options a combined role of database analyses and incorporation of biomarkers is proposed.
Original languageEnglish
Title of host publicationPerioperative Inflammation as Triggering Origin of Metastasis Development
EditorsMichael W. Retsky, Romano Demicheli
Place of PublicationCham
PublisherSpringer
Pages201-208
Number of pages8
ISBN (Electronic)9783319579436
ISBN (Print)9783319579429
DOIs
Publication statusPublished - 2017

Keywords

  • Inflammation
  • surgery
  • cancer
  • Neutrophil-to-lymphocyte ratio
  • Non-steroidal anti-inflammatory drugs
  • Perioperative

Fingerprint Dive into the research topics of 'Long Term Consequences of Acute Inflammation in Cancer Surgery'. Together they form a unique fingerprint.

  • Cite this

    Forget, P., & De Kock, M. (2017). Long Term Consequences of Acute Inflammation in Cancer Surgery. In M. W. Retsky, & R. Demicheli (Eds.), Perioperative Inflammation as Triggering Origin of Metastasis Development (pp. 201-208). Springer . https://doi.org/10.1007/978-3-319-57943-6_9